SciBase Holding AB
Tracked across 2 events · 12 articles · First seen Jun 09, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: SciBase Holding AB announced the publication of a study in the journal Allergy, demonstrating the potential of its Nevisense device as an early biomarker for atopic dermatitis. This publication strengthens the scientific evidence supporting Nevisense and could lead to increased adoption and market value for SciBase Holding AB.
Jun 09, 2026 · 6 articles
Business
SciBase Holding AB announced on September 8, 2026 that it received an additional order from Castle Biosciences under their ongoing collaboration. The order, valued at approximately $0.6 million (MSEK 5), includes the portable Nevisense Go…
Impact: SciBase is the recipient of the order, which provides additional revenue and validates its technology and collaboration. This order supports its growth and strengthens its position in dermatology diagnostics.
Sep 08, 2026 · 6 articles
90
Castle Biosciences placed order SciBase Holding ABSciBase receives...
ERGEN INTELLIGENCE
Track SciBase Holding AB live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard